Product information and disease description
Place of product in therapy
233 evidence topics · 114 sources
Aqneursa (levacetylleucine)
Ataxia-telangiectasia
- Manufacturer
- IntraBio
- Regulatory submission
- sNDA submitted March 2026 and approved September 2026
- Last updated